Pfizer New York City , NY 10008
Patient Health Impact (PHI) offers solutions that help patients and health care providers manage chronic, costly conditions, and improve outcomes and overall health. Two key entities within PHI are the Health Economics and Outcomes Research (HEOR) and Payer Insights & Access (PI&A) groups. Both groups collaborate to achieve commercial success by designing and executing strategies that generate evidentiary data that resonate with patients (and their caregivers), payors, healthcare providers and policy-makers to obtain and maintain market access, as well as to increase market uptake.
This is a US focused role. The Health Economics & Outcomes Research (HEOR) Director will work in a closely aligned fashion with the Senior Director/Team Lead (PC and RCC), Oncology PHI Cross-Functional Leadership Team (CFLT) and other functional areas within PHI as well as the brand team to ensure there is a single and coordinated view on strategy, study planning and execution and timely delivery from PHI to the Oncology BU. The HEOR Director will be a strategic partner to the US Xtandi functional Team , and a liaison with Astellas HEOR (our co-marketing partners for XTANDI) and implement an HEOR strategy that supports and help communicate the overall asset value proposition for PC . The HEOR Director will also be a strategic partner to the US Hematology cross functional Team and implement an HEOR strategy that supports and help communicate the overall asset value proposition for RCC assets.
This role will report directly into the Sr Director, HEOR, PC and dotted line into the Team Leader/Sr Director, RCC and Heme.
Independently deliver strategic thinking from an US HEOR perspective in support of our medicines; operate with a significant amount of autonomy
Be a Strategic Partner to US brand teams and provide HEOR leadership in cross-functional strategy meetings and in meetings with co-marketing partners.
Independently initiates and leads the development and execution of a multi-year US HEOR strategy that includes projects and cutting edge studies (e.g., real-world non-interventional studies, registries, etc.) to support the value of our medicines in close partnership with the cross-functional matrix team.
Lead the timely development of complex deliverables including AMCP dossiers updates, adaptations of US Budget Impact or other economic models, and innovative tools to successfully support US launch and post-launch activities for our medicines.
Strategically generate robust US Real World evidence that can be used proactively and/or reactively with US Population based decision makers (Payers, IDNs, Pathway Organizations, etc.), and support successful reimbursement and appropriate patient access for our medicines.
Lead the development of appropriate data dissemination plans and communicate evidence generated via publications, conference presentations, and other appropriate channels; work closely with Field Medical teams to disseminate evidence via appropriate channels
Prepare clear, relevant and influential written reports and presentations for a variety of audiences and effectively present information to management at Pfizer.
Represent Pfizer before appropriate scientific, medical, payer, patient & other meetings, as appropriate.
Execute in a manner that is compliant, with integrity, and follows the appropriate SOPs and Engagement policies
Lead the development of appropriate data dissemination plans and communicate in a timely manner evidence generated to various stakeholders via publications and conference presentations.
Optimal project Budget management
Minimum: Masters degree (MSc, MPH) in health services research, pharmacy administration/pharmaceutical policy, public health, epidemiology, or health economics
Minimum 8 years' experience in health outcomes and related fields, 5 of which are as part of health economics and/or outcomes research teams in a global pharmaceutical company.
Knowledge of the US health care system and Experience with US Payers or Population Based Decision Makers is desirable.
Strong methodological skills (study design, data analysis and interpretation) in cancer health services research is required
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers and influence in a matrix environment
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Demonstrated ability to influence key members of medical and commercial teams constructively and without conflict in a matrix environment
Skilled in functioning within a matrix organization where managing through influence is required
Doctoral degree (PhD, DrPH, ScD) in pharmaceutical administration/ pharmaceutical policy, health services research, public health, epidemiology, or health economics preferred
Knowledge and experience in the oncology therapeutic area is preferred
Strong understanding of Section 114 and other field materials for appropriate external dissemination in the US is desirable
Strong publication record is desirable
Change oriented, comfortable responding to unexpected demands with tight timelines; team player.
Demonstrated expert understanding of fundamental health services research methods (e.g., health economics, patient reported outcomes, research study design, database analyses, epidemiology, statistics) and external environmental trends influencing health care/pharmaceuticals in key markets worldwide.
Able to independently engage all levels of stakeholders in P&HI and the BU through strategic thinking, leading change, and building collaborative partnerships in a matrix environment
Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities.
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.